These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 22098438

  • 21. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
    Almeida González D, Cabrera de León A, Rodríguez Pérez Mdel C, Brito Díaz B, González Hernández A, García García D, Vázquez Moncholi C, Aguirre Jaime A.
    J Immunol Methods; 2010 Aug 31; 360(1-2):89-95. PubMed ID: 20600078
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, Athanassiou AE, Mitsouli-Mentzikof C.
    J BUON; 2006 Aug 31; 11(4):485-9. PubMed ID: 17309182
    [Abstract] [Full Text] [Related]

  • 23. Relationships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital.
    Banhuk FW, Pahim BC, Jorge AS, Menolli RA.
    Autoimmune Dis; 2018 Aug 31; 2018():9856910. PubMed ID: 30364021
    [Abstract] [Full Text] [Related]

  • 24. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C, Melegari A, Ballabio A, Parmeggiani M, Russo A, Battistelli L, Aloe R, Trenti T, Lippi G.
    Autoimmun Rev; 2011 Nov 31; 11(1):1-5. PubMed ID: 21741498
    [Abstract] [Full Text] [Related]

  • 25. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system.
    Gilburd B, Abu-Shakra M, Shoenfeld Y, Giordano A, Bocci EB, delle Monache F, Gerli R.
    Clin Dev Immunol; 2004 Mar 31; 11(1):53-6. PubMed ID: 15154612
    [Abstract] [Full Text] [Related]

  • 26. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W, Roy A, Kini U, Mullick S.
    Indian J Pathol Microbiol; 2010 Mar 31; 53(3):427-32. PubMed ID: 20699497
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic utility of unidentified precipitin lines (UPLs) in immune precipitation assays.
    Pajaro A, Nikoloutsopoulos T, Roberts-Thomson P.
    Pathology; 2015 Jan 31; 47(1):62-7. PubMed ID: 25474508
    [Abstract] [Full Text] [Related]

  • 28. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.
    Selmi C, Ceribelli A, Generali E, Scirè CA, Alborghetti F, Colloredo G, Porrati L, Achenza MI, De Santis M, Cavaciocchi F, Massarotti M, Isailovic N, Paleari V, Invernizzi P, Matthias T, Zucchi A, Meroni PL.
    Autoimmun Rev; 2016 Feb 31; 15(2):162-6. PubMed ID: 26524640
    [Abstract] [Full Text] [Related]

  • 29. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.
    Van Praet JT, Vander Cruyssen B, Bonroy C, Smith V, Delanghe J, De Keyser F.
    Clin Exp Rheumatol; 2009 Feb 31; 27(6):971-6. PubMed ID: 20149314
    [Abstract] [Full Text] [Related]

  • 30. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D, Vogt P, Wu X, Rose L, Tyndall A, Hasler P.
    Z Rheumatol; 2002 Oct 31; 61(5):534-44. PubMed ID: 12399881
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing.
    Van Blerk M, Bossuyt X, Humbel R, Mewis A, Servais G, Tomasi JP, Van Campenhout C, Van Hoovels L, Vercammen M, Damoiseaux J, Coucke W, Van de Walle P.
    Acta Clin Belg; 2014 Apr 31; 69(2):83-6. PubMed ID: 24724745
    [Abstract] [Full Text] [Related]

  • 33. Is high titre ANA specific for connective tissue disease?
    Vaile JH, Dyke L, Kherani R, Johnston C, Higgins T, Russell AS.
    Clin Exp Rheumatol; 2000 Apr 31; 18(4):433-8. PubMed ID: 10949716
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing.
    Craig WY, Ledue TB, Collins MF, Meggison WE, Leavitt LF, Ritchie RF.
    Clin Chem Lab Med; 2006 Apr 31; 44(10):1283-6. PubMed ID: 17032143
    [Abstract] [Full Text] [Related]

  • 38. Measurement of antinuclear antibodies: assessment of different test systems.
    Kern P, Kron M, Hiesche K.
    Clin Diagn Lab Immunol; 2000 Jan 31; 7(1):72-8. PubMed ID: 10618281
    [Abstract] [Full Text] [Related]

  • 39. Clinical and laboratory characteristics of patients with speckled pattern antinuclear antibodies.
    McMillan SA, Fay AC, Taggart AJ, McCrea JD, Roberts SD, Boyd MW, Nelson JK, Haire M.
    Ulster Med J; 1986 Oct 31; 55(2):112-7. PubMed ID: 3492803
    [Abstract] [Full Text] [Related]

  • 40. Clinical implications of autoantibodies to extractable nuclear antigens in rheumatoid arthritis patients in tertiary care hospital in Riyadh, Saudi Arabia.
    Khater ES, Al Sheik MFA.
    Egypt J Immunol; 2022 Apr 31; 29(2):87-95. PubMed ID: 35436058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.